155 related articles for article (PubMed ID: 37863959)
1. Long-term outcomes of endoscopic resection for duodenal neuroendocrine tumors.
Yi K; Kim GH; Kim SJ; Choi CW; Lee MW; Lee BE; Song GA
Sci Rep; 2023 Oct; 13(1):17908. PubMed ID: 37863959
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic submucosal resection using a ligation device without injection for duodenal neuroendocrine tumors.
Oono Y; Shinmura K; Hori K; Yoda Y; Ishii G; Ikematsu H; Yano T
Surg Endosc; 2019 Jun; 33(6):2008-2014. PubMed ID: 30604268
[TBL] [Abstract][Full Text] [Related]
3. Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor.
Matsueda K; Kanesaka T; Kitamura M; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Honma K; Miyashiro I; Ishihara R
J Gastroenterol Hepatol; 2021 Dec; 36(12):3329-3336. PubMed ID: 34142385
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic submucosal resection with a ligation device for the treatment of duodenal neuroendocrine tumors.
Osera S; Oono Y; Ikematsu H; Yano T; Kaneko K
Surg Endosc; 2016 Sep; 30(9):3928-32. PubMed ID: 26675937
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
Li QL; Zhang YQ; Chen WF; Xu MD; Zhong YS; Ma LL; Qin WZ; Hu JW; Cai MY; Yao LQ; Zhou PH
World J Gastroenterol; 2012 Oct; 18(40):5799-806. PubMed ID: 23155323
[TBL] [Abstract][Full Text] [Related]
6. Treatment Results of Endoscopic Mucosal Resection with a Ligation Device for Duodenal Neuroendocrine Tumors.
Fujimoto A; Sasaki M; Goto O; Maehata T; Ochiai Y; Kato M; Nakayama A; Akimoto T; Kuramoto J; Hayashi Y; Kameyama K; Yahagi N
Intern Med; 2019 Mar; 58(6):773-777. PubMed ID: 30449790
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.
Chen X; Li B; Wang S; Yang B; Zhu L; Ma S; Wu J; He Q; Zhao J; Zheng Z; Li S; Wang T; Liang L
Scand J Gastroenterol; 2019 Mar; 54(3):384-389. PubMed ID: 31037980
[No Abstract] [Full Text] [Related]
8. Endoscopic resection for duodenal subepithelial tumors: a single-center experience.
Kim TW; Kim GH; Park DY; Ahn S; Lim W; Lee BE; Song GA
Surg Endosc; 2017 Apr; 31(4):1936-1946. PubMed ID: 27553800
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
10. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution.
Sung HY; Kim SW; Kang WK; Kim SY; Jung CK; Cho YK; Park JM; Lee IS; Choi MG; Chung IS
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):978-83. PubMed ID: 22647741
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.
Kim J; Kim JH; Lee JY; Chun J; Im JP; Kim JS
BMC Gastroenterol; 2018 Jun; 18(1):77. PubMed ID: 29866049
[TBL] [Abstract][Full Text] [Related]
12. Duodenal neuroendocrine tumors: Short-term outcomes of endoscopic submucosal dissection performed in the Western setting.
Gupta S; Kumar P; Chacchi R; Murino A; Despott EJ; Lemmers A; Pioche M; Bourke M
Endosc Int Open; 2023 Nov; 11(11):E1099-E1107. PubMed ID: 38026782
[No Abstract] [Full Text] [Related]
13. Short- and long-term outcomes of endoscopic submucosal dissection for non-ampullary duodenal neuroendocrine tumors.
Nishio M; Hirasawa K; Ozeki Y; Sawada A; Ikeda R; Fukuchi T; Kobayashi R; Makazu M; Sato C; Maeda S
Ann Gastroenterol; 2020; 33(3):265-271. PubMed ID: 32382229
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study.
Kim GH; Kim JI; Jeon SW; Moon JS; Chung IK; Jee SR; Kim HU; Seo GS; Baik GH; Lee YC;
J Gastroenterol Hepatol; 2014 Feb; 29(2):318-24. PubMed ID: 24117946
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
[No Abstract] [Full Text] [Related]
16. Selection of appropriate endoscopic therapies for duodenal tumors: an open-label study, single-center experience.
Matsumoto S; Yoshida Y
World J Gastroenterol; 2014 Jul; 20(26):8624-30. PubMed ID: 25024618
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of endoscopic resection for well-differentiated nonampullary duodenal neuroendocrine tumors.
Wang Y; Ren Z; Shen YH; Fang XG; Li QL; Zhong YS; Zhang YQ; Chen WF; Zhou PH; Lin SL
Gastrointest Endosc; 2024 Feb; ():. PubMed ID: 38431107
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic resection of duodenal bulb neuroendocrine tumor larger than 10 mm in diameter.
Yokoyama S; Takifuji K; Tani M; Kawai M; Naka T; Uchiyama K; Yamaue H
BMC Gastroenterol; 2011 Jun; 11():67. PubMed ID: 21658277
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.
Moon CM; Huh KC; Jung SA; Park DI; Kim WH; Jung HM; Koh SJ; Kim JO; Jung Y; Kim KO; Kim JW; Yang DH; Shin JE; Shin SJ; Kim ES; Joo YE
Am J Gastroenterol; 2016 Sep; 111(9):1276-85. PubMed ID: 27377520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
